The efficacy of tenoxicam in patients suffering from rheumatoid arthritis (including assessments of quantified articular scintigraphic data).
Every doctor faced with the task of testing a drug is well aware of the difficulty of making his or her results objective. In designing test procedures, methods need to be found which are unaffected by the subjective views of either the testing doctor or the patients undergoing the treatment. This study was designed taking this into account, using scintigraphic joint measurements in patients with chronic rheumatoid arthritis (RA) to record comparable data. Even this method, however, despite its indisputable scientific accuracy, requires clinical interpretation.
Berg
D
D
Deutsche Klinik für Diagnostik, Fachbereich Rheumatologie, Wiesbaden, FRG.
Scholz
H J
HJ
D000284:Administration, Oral; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000000981:diagnostic imaging / Q000188:drug therapy*; D003936:Diagnosis, Computer-Assisted; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D007596:Joints / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D010894:Piroxicam / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011877:Radionuclide Imaging; D013670:Sodium Pertechnetate Tc 99m
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam; D013670:Sodium Pertechnetate Tc 99m; C032801:tenoxicam